It is our goal at Ewopharma to bring much needed targeted treatments to patients in Central Eastern Europe (CEE) and Switzerland. Ewopharma is the bridge for pharmaceutical companies and brands from across the globe to access our markets. We are a one-stop shop for market access and commercialization in 15 countries in CEE and Switzerland. We are dedicated to niche indications and diseases with high unmet medical need. In the field of orphan drugs, we have successfully launched several break-through therapies. Our partners in the orphan field include Biogen, Otsuka, Santhera and Eisai. Ewopharma has its headquarters in Switzerland and 15 subsidiaries in CEE and employs 330 highly qualified staff.